Aydın Sibel Zehra, Kimyon Gezmiş, Özişler Cem, Tarhan Emine Figen, Günal Esen Kasapoğlu, Küçük Adem, Omma Ahmet, Solmaz Dilek, Ersözlü Emine Duygu, Yıldız Fatih, Tufan Müge Aydın, Çınar Muhammet, Mercan Rıdvan, Yavuz Şule, Alhussain Fatıma Arslan, Erden Abdulsamet, Can Meryem, Çetin Gözde Yıldırım, Kılıç Levent, Bakırcı Sibel, Al Osaimi Noura, Kalyoncu Umut
Division of Rheumatology, Department of Internal Medicine, University of Ottawa School of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Division of Rheumatology, Department of Internal Medicine, Hatay Mustafa Kemal University School of Medicine, Hatay, Turkey.
Eur J Rheumatol. 2020 Apr;7(2):64-67. doi: 10.5152/eurjrheum.2019.19126. Epub 2020 Jan 6.
Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology.
Within the PsA international database (PSART-ID), 571 patients had PSI, while 322 of these also showed body surface area (BSA). Correlations between PSI, BSA, and other patient- and physician-reported outcomes were investigated.
There was a good correlation between PSI and BSA (r=0.546, p<0.001), which was even higher for mild psoriasis (BSA<3 (n=164): r=0.608, p<0.001). PSI significantly correlated with fatigue, pain, and patient and physician global parameters (p<0.001).
PSI has a good correlation with other patient- and physician-reported outcomes, and our findings support its use in rheumatology practice.
我们的目的是测试银屑病症状量表(PSI)(一种患者报告结局)在风湿病范围内评估银屑病严重程度的有效性。
在银屑病关节炎国际数据库(PSART-ID)中,571例患者有PSI数据,其中322例还记录了体表面积(BSA)。研究了PSI、BSA与其他患者及医生报告结局之间的相关性。
PSI与BSA之间存在良好的相关性(r=0.546,p<0.001),对于轻度银屑病(BSA<3,n=164),相关性更高(r=0.608,p<0.001)。PSI与疲劳、疼痛以及患者和医生整体参数显著相关(p<0.001)。
PSI与其他患者及医生报告结局具有良好的相关性,我们的研究结果支持其在风湿病实践中的应用。